suloctidil and Intermittent-Claudication

suloctidil has been researched along with Intermittent-Claudication* in 5 studies

Reviews

1 review(s) available for suloctidil and Intermittent-Claudication

Article

Year

Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.

Agents and actions. Supplements, 1984, Volume: 15

Topics: Anticoagulants; Arteriosclerosis; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Platelet Aggregation; Platelet Factor 4; Suloctidil; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine

1984

Trials

4 trial(s) available for suloctidil and Intermittent-Claudication

Article	Year
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries. Agents and actions. Supplements, 1984, Volume: 15 Topics: Anticoagulants; Arteriosclerosis; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Platelet Aggregation; Platelet Factor 4; Suloctidil; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine	1984
Intermittent claudication: Suloctidil v.s. placebo treatment. VASA. Zeitschrift fur Gefasskrankheiten, 1984, Volume: 13, Issue:2 Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intermittent Claudication; Male; Middle Aged; Propanolamines; Suloctidil	1984
[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol]. La Clinica terapeutica, 1983, Mar-15, Volume: 104, Issue:5 Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Propanolamines; Random Allocation; Suloctidil; Theophylline; Time Factors; Xanthinol Niacinate	1983
A double-blind trial of suloctidil v. placebo in intermittent claudication. The British journal of surgery, 1982, Volume: 69, Issue:1 In a recent double-blind trial lasting over 6 months, 40 patients suffering from intermittent claudication were randomly allocated to receive 300 mg of suloctidil per day or exactly matching placebo capsules. In addition to treadmill walking distance, other objective criteria including ankle blood pressure response and muscle blood flow measured by 133Xe clearance were used to assess the effectiveness of therapy. Nine patients (4 in the suloctidil group and 5 controls) did not complete the trial according to the protocol. Of the remaining 31 patients, 17 were in the control group and 14 received suloctidil. A significant improvement in the absolute walking distance, the level of beta-thromboglobulin (beta TG) compared to pre-therapy value and the time for the ankle pressure index to return to the pre-exercise value was observed in patients receiving suloctidil. Topics: Adult; Aged; beta-Thromboglobulin; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Physical Exertion; Propanolamines; Suloctidil	1982

Other Studies

1 other study(ies) available for suloctidil and Intermittent-Claudication

Article	Year
[A new preparation for peripheral arterial occlusive diseases]. Die Medizinische Welt, 1982, Jan-08, Volume: 33, Issue:1 Topics: Arterial Occlusive Diseases; Humans; Intermittent Claudication; Propanolamines; Suloctidil	1982